Theravance Biopharma, Inc. (TBPH): Weighted Average Diluted Shares
51.51M
Year ended 2025-12-31
-11.2%
3-year compound annual growth
-3.7%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 51.51M | +5.4% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | 48.85M | -11.7% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | 55.30M | -24.9% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | 73.59M | +5.9% | 2024-03-01, From 2022-01-01 |
| 2021-12-31 | 69.46M | +11.4% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | 62.34M | +12.1% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | 55.61M | +3.0% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | 53.97M | +3.1% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | 52.35M | n/a | 2020-02-27, From 2017-01-01 |